Elimination Half-Life of Trimethoprim-Sulfamethoxazole
In patients with normal renal function, the elimination half-life of trimethoprim is 8-10 hours and sulfamethoxazole is 10 hours 1.
Pharmacokinetic Details
The FDA drug label provides the definitive pharmacokinetic parameters for TMP-SMX 1:
- Trimethoprim half-life: 8-10 hours
- Sulfamethoxazole half-life: 10 hours
- Time to peak levels: 1-4 hours after oral administration
- Detectable drug levels: Present in blood 24 hours after administration
Both components are rapidly absorbed following oral administration, with peak blood levels occurring within 1-4 hours. Steady-state concentrations are achieved after 3 days of twice-daily dosing.
Impact of Renal Function
The elimination half-life increases significantly in patients with impaired renal function, requiring dosage adjustments 1. Research confirms this relationship:
- In a pharmacokinetic study, half-lives correlated directly with serum creatinine levels (r = +0.85 for trimethoprim, r = +0.39 for sulfamethoxazole) 2
- The half-life increases with age, partly due to declining renal function 1
- In geriatric patients, renal clearance of trimethoprim was significantly lower (19 mL/h/kg vs. 55 mL/h/kg in young adults) 1
Clinical Implications
For patients with creatinine clearance <30 mL/min or on hemodialysis, dosing intervals must be extended to account for prolonged elimination 2. The dosing interval in hours should be increased to 12 times the serum creatinine level in mg/dL (maximum 48 hours).
Primary excretion is renal (84.5% for total sulfonamide, 66.8% for trimethoprim recovered in urine within 72 hours), occurring through both glomerular filtration and tubular secretion 1.